DexCom is trading at $84.78, down 4.18%, amid a sharp market sell-off; this backdrop is a plausible, not confirmed, explanation for the decline. - No clear DexCom-specific announcement explaining the November 5 decline surfaced in available search results. - The latest company news found was its previously announced Canadian product launch; technology shares were pressured by regulatory concerns and broader risk-off sentiment.